It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. After-hours trades for Horizon Therapeutics Public Limited Company (HZNP) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.02, or 0.02%, to $115.39. The Horizon Therapeutics Public Limited Company has recorded 70,596 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that Horizon Therapeutics plc (“Horizon”) Rule 2.12 Announcement.
Horizon Therapeutics Public Limited Company is listed on the NASDAQ in the Healthcare sector while operating in the Drug Manufacturers – General industry. At the end of the last regular session, the stock closed at $115.37 and fluctuated between $115.48 as its day high and $115.14 as its day low. The current market capitalization of Horizon Therapeutics Public Limited Company is $26.42B. A total of 5.41 million shares were traded on the day, compared to an average of 2.24M shares.
Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, HZNP has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 26 BUYs and 32 SELLs from insiders. Insiders purchased 796,419 shares during that period but sold 507,379.
In the most recent transaction, Pasternak Andy sold 27,129 shares of HZNP for 113.03 per share on Jan 17. After the transaction, the EVP, Chief Strategy Officer now owns 56,338 company shares. In a previous transaction on Jan 13, Cox Aaron sold 36,148 shares at 113.17 per share. HZNP shares that EVP, Chief Financial Officer owns now total 277.
Among the insiders who sold shares, SHERMAN JEFFREY W disposed of 3,368 shares on Jan 11 at a per-share price of $113.10. This resulted in the EVP and Chief Medical Officer holding 36,171 shares of HZNP after the transaction. In another insider transaction, SHERMAN JEFFREY W sold 3,368 shares at $113.05 per share on Jan 10. Company shares held by the EVP and Chief Medical Officer now total 39,539.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for HZNP in the last 3 months, the mean price target is $116.50 with high estimates of $116.50 and low estimates of $116.50. In terms of 52-week highs and lows, HZNP has a high of $115.70 and a low of $60.03.
As of this writing, HZNP has an earnings estimate of $1.22 per share for the current quarter. EPS was calculated based on a consensus of 6 estimates, with a high estimate of $1.46 per share and a lower estimate of $0.93. The company reported an EPS of $0.83 in the last quarter, which was -25.90% lower than expectations of $1.12.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. HZNP’s latest balance sheet shows that the firm has $1.58B in Cash & Short Term Investments as of fiscal 2021. There were $2.57B in debt and $886.57M in liabilities at the time. Its Book Value Per Share was $23.22, while its Total Shareholder’s Equity was $4.67B.
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for HZNP is Buy with a score of 3.00.